BVS - Bioventus Non-GAAP EPS of -$0.26 misses by $0.10 revenue of $119.06M beats by $2.48M
2023-05-16 16:54:07 ET
- Bioventus press release ( NASDAQ: BVS ): Q1 Non-GAAP EPS of -$0.26 misses by $0.10 .
- Revenue of $119.06M (+1.5% Y/Y) beats by $2.48M .
- 2023 Outlook: As previously disclosed, the Company has not provided financial guidance for fiscal 2023. However, given the first quarter financial results and steps the Company has taken to enhance profitability, the company is confident in achieving Adjusted EBITDA of at least $68 million for fiscal 2023. This outlook excludes the Wound Business, with annual revenues of approximately $40 million, and Adjusted EBITDA of approximately $5 million.
For further details see:
Bioventus Non-GAAP EPS of -$0.26 misses by $0.10, revenue of $119.06M beats by $2.48M